AARTI DRUGS
Quarterly Results Analysis [Mar2026]
AARTI DRUGS Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹720 Cr | ₹602 Cr | ₹653 Cr | ₹591 Cr | ₹677 Cr | ₹557 Cr | ₹598 Cr | ₹555 Cr |
| Expenses | ₹625 Cr | ₹547 Cr | ₹569 Cr | ₹516 Cr | ₹583 Cr | ₹495 Cr | ₹531 Cr | ₹490 Cr |
| Operating Income | ₹96 Cr | ₹55 Cr | ₹84 Cr | ₹74 Cr | ₹93 Cr | ₹62 Cr | ₹67 Cr | ₹65 Cr |
| Other Income | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹12 Cr | ₹1 Cr | ₹1 Cr |
| Interest | ₹8 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr |
| Depreciation | ₹18 Cr | ₹18 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr |
| Profit Before Tax | ₹70 Cr | ₹29 Cr | ₹60 Cr | ₹51 Cr | ₹71 Cr | ₹51 Cr | ₹46 Cr | ₹44 Cr |
| Profit After Tax | ₹55 Cr | ₹41 Cr | ₹45 Cr | ₹54 Cr | ₹63 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr |
| EPS | ₹6.05 | ₹4.44 | ₹4.96 | ₹5.91 | ₹6.89 | ₹4.06 | ₹3.84 | ₹3.62 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AARTI DRUGS | -0.7% | 3.2% | -20.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.5% | -3% | 6.7% |
| DIVIS LABORATORIES | -2.2% | -4.5% | 0.1% |
| TORRENT PHARMACEUTICALS | 0.8% | 2.3% | 43.9% |
| CIPLA | 0.4% | -4% | -7.8% |
| DR REDDYS LABORATORIES | 0.8% | -1.8% | -3.4% |
| MANKIND PHARMA | -0.4% | -3.3% | 1% |
| LUPIN | 0.5% | 0.7% | 15% |
| ZYDUS LIFESCIENCES | -1.6% | 9.7% | 13.5% |
AARTI DRUGS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 19.71 % |
| Y-o-Y | 6.43 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹720 Cr | 19.71 | |
| Dec2025 | ₹602 Cr | -7.82 | |
| Sep2025 | ₹653 Cr | 10.55 | |
| Jun2025 | ₹591 Cr | -12.74 | |
| Mar2025 | ₹677 Cr | 21.59 | |
| Dec2024 | ₹557 Cr | -6.97 | |
| Sep2024 | ₹598 Cr | 7.74 | |
| Jun2024 | ₹555 Cr | - | |
AARTI DRUGS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 74.06 % |
| Y-o-Y | 2.66 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹96 Cr | 74.06 | |
| Dec2025 | ₹55 Cr | -34.69 | |
| Sep2025 | ₹84 Cr | 13.77 | |
| Jun2025 | ₹74 Cr | -20.62 | |
| Mar2025 | ₹93 Cr | 51.17 | |
| Dec2024 | ₹62 Cr | -7.93 | |
| Sep2024 | ₹67 Cr | 3.22 | |
| Jun2024 | ₹65 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 45.36 % |
| Y-o-Y | -3.55 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 13.3% | 45.36 | |
| Dec2025 | 9.15% | -29.12 | |
| Sep2025 | 12.91% | 2.87 | |
| Jun2025 | 12.55% | -8.99 | |
| Mar2025 | 13.79% | 24.35 | |
| Dec2024 | 11.09% | -1.07 | |
| Sep2024 | 11.21% | -4.19 | |
| Jun2024 | 11.7% | - | |
AARTI DRUGS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 36.28 % |
| Y-o-Y | -11.96 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹55 Cr | 36.28 | |
| Dec2025 | ₹41 Cr | -10.21 | |
| Sep2025 | ₹45 Cr | -16.32 | |
| Jun2025 | ₹54 Cr | -14.02 | |
| Mar2025 | ₹63 Cr | 69.24 | |
| Dec2024 | ₹37 Cr | 6.09 | |
| Sep2024 | ₹35 Cr | 5.08 | |
| Jun2024 | ₹33 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 13.80 % |
| Y-o-Y | -17.35 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 7.67 % | 13.80 | |
| Dec2025 | 6.74 % | -2.60 | |
| Sep2025 | 6.92 % | -24.29 | |
| Jun2025 | 9.14 % | -1.51 | |
| Mar2025 | 9.28 % | 39.34 | |
| Dec2024 | 6.66 % | 14.04 | |
| Sep2024 | 5.84 % | -2.50 | |
| Jun2024 | 5.99 % | - | |
AARTI DRUGS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 36.26 % |
| Y-o-Y | -12.19 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹6.05 | 36.26 | |
| Dec2025 | ₹4.44 | -10.48 | |
| Sep2025 | ₹4.96 | -16.07 | |
| Jun2025 | ₹5.91 | -14.22 | |
| Mar2025 | ₹6.89 | 69.70 | |
| Dec2024 | ₹4.06 | 5.73 | |
| Sep2024 | ₹3.84 | 6.08 | |
| Jun2024 | ₹3.62 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD